Infection: Is it a cause of bladder cancer?

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue SUPPL.218, 2008, Pages 79-84

  Abol Enein, Hassan ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bacterial; Bladder; Cancer; Infection; Parasitic; Viral

Indexed keywords

CYCLOPHOSPHAMIDE;

BK VIRUS; BLADDER CARCINOMA; CANCER RISK; CELL TRANSFER; CONFERENCE PAPER; DISEASE COURSE; GONORRHEA; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SPINAL CORD INJURY; URINARY TRACT INFECTION; UROLITHIASIS; VERRUCA VULGARIS; WART VIRUS; ANIMAL; BLADDER TUMOR; HEALTH; HUMAN; INCIDENCE; INFECTION; REVIEW; RISK FACTOR;

ANIMALS; HUMANS; INCIDENCE; INFECTION; RISK FACTORS; URINARY BLADDER NEOPLASMS; WORLD HEALTH;

EID: 52949146038     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/03008880802325309     Document Type: Conference Paper

References (40)

1. Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007;25:260-8.
2. Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 1995;103:131-42.
3. Silverman D, Hartge P, Morrison A, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992;6:1-30.
4. Hartge P, Silverman D, Hoover R, Austin D, Altman R, Scharier C. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 1987;78:1119-25.
5. Fergusson AR. Associated bilharziasis and primary malignant diseases of the urinary bladder, with observations on a series of 40 cases. J Pathol Bacteriol 1911;16:76-94.
6. Clayson DB, Cooper EH. Cancer of the urinary tract. Adv Cancer Res 1970;13:271.
7. Cohen SM, Johansson SL. Epidemiology and etiology of bladder cancer. Urol Clin N Am 1992;19:421-8.
8. Cohen SH, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007.
9. Cohen SH, Purtilo DT, Ellwein LB. Pivotal role of increased cell proliferation in human carcinogenesis. Mod Pathol 1991;4:371.
10. El-Bolkainy MN. Schistosomiasis and bladder cancer. In: Bryan GT, Cohen SH, editors. The pathology of bladder cancer. Boca Raton, FL: CRC Press; 1983. pp 57-90.
11. Davis CP, Cohen MS, Mackett RL, Anderson MD, Warren MM. Urothelial hyperplasia and neoplasia. III. Detection of nitrosamine production with different bacterial genera in chronic urinary tract infections of rats. J Urol 1991;145:875-80.
12. Radomski JL, Greenwald D, Hearn WL, Block NL, Woods FM. Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. J Urol 1978;120:48-50.
13. Davis CP, Cohen SM, Groeber MB, Andersson MD, Warren MM. Urothelial hyperplasia and neoplasia: a response to chronic urinary tract infection in rats. J Urol 1984;132:1025-31.
14. Mirva M, Stuehr DJ, Marietta MA, Wishok JS, Tannenbaum SR. N-Nitrosamine formation by macrophage. In: Bartsch H, O'Neill IK, Schulte-Hermann R, editors. Relevance of N-nitroso compounds to human cancer: exposure and mechanisms. Lyon: IARC Scientific Publication, 84;1987. pp 340-4,.
15. Kjaer SK, Knudsen JB, Sörensen BL, Möller Jensen OL. The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary tract infection. Acta Oncol 1989;28:631-6.
16. La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Savodelli R. Genital and urinary tract diseases and bladder cancer. Cancer Res 1991;51:629-31.
17. Gonzalez CA, Errezola M, Izarzugaza I, Riboli E, Nebot M, Escolar A, López-Abente Gl. Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 1991;27:498-500.
18. Piper JM, Matanoski GM, Tonascia J. Bladder cancer in young women. Am J Epidemiol 1986;123:1033-42.
19. Claude J, Kunze E, Frentzel-Beyme R, Schenider J, Paczkowski KL, Schubert H. Lifestyle and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 1986;124:578-89.
20. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984;119:510-5.
21. Howe G, Burch J, Miller A, Cook GM, Esteve J, Morrison B, et al. Tobacco use, occupation, coffee, various nutrients and bladder cancer. J Natl Cancer Inst 1980;64:701-3.
22. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977;118:967-71.
23. Bickel A, Culkin DJ, Wheeler JSJ. Bladder cancer in spinal cord injury patients. J Urol 1991;146:1240-2.
24. Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 2004;93:216-20.
25. Hamid R, Bycroft J, Arya M, Shah PJ. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol 2003;170:425-7.
26. De Ridder D, Van Poppel H, Demonty L, D'Hooghe B, Gonsette R, Carton H, et al. Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol 1988;159:1881-4.
27. Mommsen S, Sell A. Prestatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer. Urol Res 1983;11:49-52.
28. Michaud DS, Platz EA, Giovannucci E. Gonorrhea and male bladder cancer in a prospective study. Br J Cancer 2007;96:169-71.
29. Westenend PJ, Stoop JA, Hendrike JGH. Human papilloma viruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary tract. BJU Int 2001;88:198-201.
30. Gutierrez J, Jimenez A, Luna JD, Soto MJ, Sorlozano H. Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol 2006;176:2474-81.
31. Jimenez PA, Martinez TJL, Pareja VM, Arrabal MM, Valle DGF, Lopez LV, et al. Statistical analysis of the influence of the virus of papilloma human in the development of the vesical carcinoma. Acta Urol Esp 2007;31:469-76.
32. Stanley M. The end for genital human papilloma virus infection? Lancet Oncol 2005;6:256.
33. Moonen PMJ, Bakkers JMJE, Kiemeney LALH, Schalken JA, Melchers WJG, Witjes JA. Human papilloma virus DNA and P53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9.
34. Cai T, Mondaini N, Bartoletti R, Mazzoli S. Letter to the editor. Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer. Eur Urol 2008;53:858-9.
35. Tirelli U, Lazzarin A, editors, for the Gruppo Italiano Tumori e infezione da HIV (GICAT). Tumori e Infezione de HIV-9. Usmate: Biomedia; 2004. p 103.
36. Manfredi R. HIV disease and advanced age: an increasing therapeutic challenge. Drugs Aging 2002;19:647-69.
37. Manfredi R. HIV infection and advanced age. Emerging epidemiological, clinical and management issues. Ageing Res Rev 2004;3:31-54.
38. Kwak EJ, Vilchez RA, Randhwa P, Shapiro R, Butel JS, Kusne S. Pathogenesis and management of polyoma virus infection in transplant recipients. Clin Infect Dis 2002;35:1081-7.
39. Newton R, Ribeiro T, Casabonne D, Alvarez E, Touze A, Key T, Coursaget P. Antibody levels against BK virus and prostate, kidney and bladder cancer in the EPIC-Oxford Cohort. Br J Cancer 2005;93:1305-6.
40. Kaku N, Kashima K, Daa T, Nakayama I, Yokoyama S. Herpes simplex infection in urothelial carcinoma. Virchows Arch 2004;445:68-73.